Home » Stocks » Kiromic BioPharma

Kiromic BioPharma, Inc. (KRBP)

Stock Price: $11.29 USD -0.21 (-1.83%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 56.33M
Revenue (ttm) n/a
Net Income (ttm) -16.28M
Shares Out 7.33M
EPS (ttm) -2.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $11.29
Previous Close $11.50
Change ($) -0.21
Change (%) -1.83%
Day's Open 11.20
Day's Range 10.75 - 11.50
Day's Volume 119,034
52-Week Range 10.30 - 11.90

More Stats

Market Cap 56.33M
Enterprise Value 54.76M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.33M
Float n/a
EPS (basic) n/a
EPS (diluted) -2.22
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 26.88
Revenue n/a
Operating Income n/a
Net Income -16.28M
Free Cash Flow n/a
Net Cash 1.57M
Net Cash / Share 0.31
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-3.68-2.55
Net Income-3.73-3.82
Shares Outstanding2.862.86
Earnings Per Share-1.39-1.33
Operating Cash Flow-2.91-2.15
Capital Expenditures-0.30-0.14
Free Cash Flow-3.22-2.29
Cash & Equivalents1.930.38
Net Cash / Debt1.930.38
Book Value1.980.27
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Kiromic BioPharma, Inc.
Country United States
Employees 13
CEO Maurizio Chiriva-Internati

Stock Information

Ticker Symbol KRBP
Stock Exchange NASDAQ
Sector Health Technology
Industry Biotechnology
Unique Identifier NASDAQ: KRBP
IPO Date October 16, 2020


Kiromic BioPharma is a target discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology. Our proprietary target discovery engine is called "Diamond." Kiromic's Diamond is big data science meeting target identification, dramatically compressing man-years and billions of drug development dollars to develop a live drug. Without Kiromic's Diamond, the management of all the data required to solve the Target Identification puzzle is both challenging and inefficient. Normal data required for target identification would require manual analysis of thousands of cancer tissue samples with billions of data points, looking at millions of mutations, and poring over thousands of publications on oncology and targets.